When?
Start:
May 19, 2022
12:00 PM
End:
May 19, 2022
1:00 PM
Speakers
Débora Sobral,
Founder and CEO, ClinBiz
Lief Kuse
Trailblazer of Drug Development Outsourcing, Pharall GmbH
Innovative financing strategies for biotechs; Reducing capital investment up to 20% with clinical trial scenario modelling. Leif Kuse, CEO of Pharall GmbH, the first group purchasing organization for clinical trial services.
Published on June 3, 2021
Strengthen your processes and increase data-driven decision-making for faster study start-ups.
Enjoying this release?
When?
Start:
May 19, 2022
12:00 PM
End:
May 19, 2022
1:00 PM
Speakers
Débora Sobral,
Founder and CEO, ClinBiz
Lief Kuse
Trailblazer of Drug Development Outsourcing, Pharall GmbH
Strengthen your processes and increase data-driven decision-making for faster study start-ups.
Enjoying this release?
RESOURCES
Explore Expert Insights and Resources for Clinical Excellence
Webinars
Oversight is no longer periodic or document-driven. It must be continuous, risk-based, and fully traceable across vendors, studies, and services.
Read more
Blogs
From Vendor Management to Real-Time Control in Clinical Trials
Read more
Case Studies
Faced with inefficiencies, compliance risks, and fragmented communication, a biopharma company dramatically enhanced its vendor governance by implementing VISION!
Read more
DEMO
Request a demo
Discover how Clinical Maestro®’s advanced solutions can streamline your clinical trial operations. Request a personalized demo to explore how our tools transform budgeting, vendor management, and outsourcing efficiency for pharma and biotech.
